Home
Storia in 1 fonti
Jubilant Ingrevia’s ₹2,000-crore specialty bet starts paying off as CDMO, nutrition drive growth
Jubilant Ingrevia’s ₹2,000-crore investment in specialty chemicals and nutrition is yielding growth, offsetting challenges in commodity chemicals.
Raccontata da
thehindubusinessline.com
Timeline cronologica
- ·
Jubilant Ingrevia Q4 profit rises 17%, revenue grows to ₹1,188 cr
Jubilant Ingrevia Ltd on Tuesday reported a 17 per cent increase in consolidated net profit to ₹86.44 crore for the quarter ended March.
- ·
Jubilant Ingrevia’s ₹2,000-crore specialty bet starts paying off as CDMO, nutrition drive growth
Jubilant Ingrevia’s ₹2,000-crore investment in specialty chemicals and nutrition is yielding growth, offsetting challenges in commodity chemicals.